Identification and characterization of neogenin, a DCC-related gene

Oncogene

Volumn 14, Issue 10, 1997, Pages 1129-1136

  Meyerhardt, Jeffrey A ^a   Look, A Thomas ^c   Bigner, Sandra H ^d   Fearon, Eric R ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain tumor; Chromosome 18q; DCC (deleted in colorectal cancer) gene; Gene expression; Neuroblastoma; Tumor suppressor gene

Indexed keywords

COMPLEMENTARY DNA; MEMBRANE PROTEIN; NEOGENIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 15Q; CHROMOSOME 18Q; COLORECTAL TUMOR; CONTROLLED STUDY; DNA TRANSCRIPTION; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL TRACT; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MEDULLOBLASTOMA; NERVOUS SYSTEM DEVELOPMENT; NEUROBLASTOMA; NORTHERN BLOTTING; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX TUMOR;

GALLUS GALLUS;

EID: 0030981877     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200935     Document Type: Article

References (40)

1. Ah-See KW, Cooke G, Pickford IR, Soutar D and Balmain A. (1994). Cancer Res., 54, 1617-1621.
2. Bishop JM. (1991). Cell, 64, 235-248.
3. Chan S, Su M-W, Culotti JG and Hedgecock EM. (1995). Worm Breeder's Gazette, 13, 48.
4. Cho KR and Fearon ER. (1995). Curr. Opin. Gen. Devel., 5, 72-78.
5. Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Presinger AC, Hedge P, Silverman GA and Vogelstein B. (1994). Genomics, 19, 525-531.
6. Chuong C-M, Jiang T-X, Yin E and Widelitz RB. (1994). Dev. Biol., 164, 383-397.
7. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, Podratz KC and Jenkins RB. (1993). Cancer Res., 53, 2393-2398.
8. Cooper HM, Armes P, Britto J, Gad J and Wilks AF. (1995). Oncogene, 11, 2243-2254.
9. Culotti JG. (1994). Curr. Opin. Genet. Devel., 4, 587-595.
10. Ekstrand BC, Mansfield TA, Bigner SH and Fearon ER. (1995). Oncogene, 11, 2393-2402.
11. Fearon ER. (1995). Clinical Oncology. Abeloff MD, Armitage JO, Lichter AS and Niederhuber JE. (eds). Churchill Livingstone: New York, pp. 11-40.
12. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler WK and Vogelstein B. (1990). Science, 247, 49-56.
13. Franke U. (1994). Cytogenet. Cell Genet., 65, 206-219.
14. Fujino T, Risinger JL, Collins NK, Liu F-S, Nishii H, Takahashi H, Westphal E-M, Barrett JC, Sasaki H, Kohler MF, Berchuck A and Boyd J. (1994). Cancer Res., 54, 4294-4298.
15. Hahn SA, Seymour AB, Shamsul Hoque ATM, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein Cl, Fisher A, Yeo CJ, Hruban RH and Kern SE. (1995). Cancer Res., 55, 4670-4675.
16. Hedgecock EM, Culotti JG and Hall DH. (1990). Neuron, 2, 61-85.
17. Hedrick L, Cho K, Fearon ER, Wu T-C, Kinzler KW and Vogelstein B. (1994). Genes Dev., 8, 1174-1183.
18. Ishii N, Wadsworth WG, Stern BD, Culotti JG and Hedgecock EM. (1992). Neuron. 9, 873-881.
19. Kennedy TE and Tessier-Lavigne M. (1995). Curr. Opin. in Neurobiology, 5, 83-90.
20. Kennedy TE, Serafini T, de la Torre JR and Tessier-Lavigne M. (1994). Cell, 78, 425-435.
21. Klingelhutz AJ, Hedrick L, Cho KR and McDougall JK. (1995). Oncogene, 10, 1581-1586.
22. Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME and Law MG. (1994). Cancer Res., 54, 531-538.
23. Knudson AG. (1993). Proc. Natl. Acad. Sci. USA, 90, 10914-10921.
24. Kraft T, Tardiff J, Krauter KS and Leinwand LA. (1988). Biotechniques, 6, 544-546.
25. Lasko D, Cavenee WK and Nordenskjold M. (1991). Annu. Rev. Genet., 25, 281-314.
26. Mitra AB, Murty VVS, Li RG, Pratap M, Luthra UK and Chaganti RSK. (1994). Cancer Res., 54, 4481-4487.
27. Pierceall WE, Reale MA, Candia AF, Wright CVE, Cho KR and Fearon ER (1994). Dev. Biol., 166, 654-665.
28. Reale MA, Hu G, Zafar AI, Getzenberg RH, Levine SM and Fearon ER. (1994). Cancer Res., 54, 4493-4501.
29. Reale MA, Reyes-Mugica M, Pierceall WE, Rubinstein MC, Hedrick L, Cohn SL, Nakagawara A, Brodeur GM and Fearon ER. (1996). Clin. Cancer Res., 2, 1097-1102.
30. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G and Nakamura Y. (1990). Cancer Res., 50, 7184-7189.
31. Schold SC, Hullard DE, Bigner SH, Jones TR and Bigner DD. (1983). J. Neurooncol., 1, 5-14.
32. Serafini T, Kennedy TE, Galko MJ, Mirzayan C, Jessell TM and Tessier-Lavigne M. (1994). Cell, 78, 409-424.
33. Seymour AB, Hruban RH, Redston M, Caldas C, Powell SM, Kinzler KW, Yeo CJ and Kern SE. (1994). Cancer Res., 54, 2761-2764.
34. Tsuchiya E, Nakamura Y, Weng S-Y, Nakagawa K, Tsuchiya S, Sugano H and Kitagawa T. (1992). Cancer Res., 52, 2478-2481.
35. Vielmetter J, Kayyem JF, Roman JM and Dreyer WJ. (1994). J. Cell Biol., 127, 2009-2020.
36. Vogelstein B, Fearon ER, Hamilton SR, Preisinger AC, Willard HF, Michelson AM, Riggs AD and Orkin SH. (1987). Cancer Res., 47, 4806-4813.
37. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits A and Bos J. (1988). N. Eng. J. Med., 319, 525-532.
38. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y and White R. (1989). Science, 244, 207-211.
39. Wick W, Petersen I, Schmutzler RK, Wolfarth B, Lenartz D, Bierhoff E, Hummerich J, Muller DJ, Stangl AP, Schramm J, Wiestler OD and von Diemling A. (1996). Oncogene, 12, 973-978.
40. Yamaguchi T, Toguchida J, Yamamuro T, Kotoura Y, Takada N, Kawaguchi N, Kaneko Y, Nakamura Y, Sasaki MS and Ishizaki K. (1992). Cancer Res., 52, 2419-2423.